Can I Take Melatonin with AndroGel?

What Kind of Interaction Exists Between Melatonin and AndroGel?

The interaction between melatonin and AndroGel is pharmacodynamic rather than pharmacokinetic. Both agents influence metabolic and hormonal physiology independently, but their effects can converge in ways that matter for men on testosterone replacement therapy (TRT).

Pharmacokinetic interactions occur when one drug changes the absorption, distribution, metabolism, or excretion of another. Pharmacodynamic interactions occur when two compounds act on the same physiological pathway, amplifying or opposing each other's effects even though neither compound changes the other's blood level.

Why There Is No Pharmacokinetic Collision

AndroGel delivers testosterone transdermally. After absorption through the skin, testosterone is metabolized primarily by the CYP3A4 enzyme system in the liver, with secondary clearance through 5-alpha-reductase and aromatase pathways. Melatonin, by contrast, is metabolized almost entirely by CYP1A2 in the liver, with a small contribution from CYP1A1 [1]. Because they use different enzymatic routes, neither compound meaningfully raises or lowers the serum level of the other.

A 2021 review published in the British Journal of Clinical Pharmacology confirmed that melatonin's CYP1A2-driven metabolism does not overlap with the major androgen-clearance pathways, and no clinically significant pharmacokinetic interaction has been reported in the peer-reviewed literature [2].

Where the Pharmacodynamic Concern Lives

The overlap that matters involves glucose metabolism. Testosterone therapy in hypogonadal men improves insulin sensitivity over the long term, an effect documented across multiple randomized trials [3]. Melatonin, at supraphysiologic doses (generally above 1 to 3 mg), has been shown in controlled studies to impair early-phase insulin secretion by acting on melatonin receptors (MT1 and MT2) expressed on pancreatic beta cells [4]. A 2019 study in Diabetologia (N=23 healthy volunteers) showed that 4 mg melatonin taken 30 minutes before a glucose load reduced first-phase insulin secretion by approximately 17%, without a corresponding fall in blood glucose in non-diabetic subjects [4].

For a man on AndroGel who is already metabolically borderline, adding supraphysiologic melatonin doses could transiently blunt the insulin response enough to matter.

Does Melatonin Affect Testosterone Levels Directly?

The relationship between melatonin and testosterone is more complex than most online sources acknowledge. Animal data from the 1980s and early 1990s suggested that melatonin could suppress LH pulsatility, which would lower testosterone in seasonally breeding mammals. Human data tell a different story.

What Human Trials Show

A double-blind crossover study published in the Journal of Clinical Endocrinology and Metabolism (N=30 healthy men) found that 6 mg melatonin taken nightly for 4 weeks did not significantly change morning serum total testosterone, LH, or FSH compared to placebo [5]. The authors noted that human gonadotroph cells appear far less sensitive to melatonin-driven suppression than rodent cells.

A separate 12-week randomized trial in men aged 50 to 65 years (N=47) found no statistically significant change in free testosterone or sex-hormone-binding globulin (SHBG) after nightly melatonin 2 mg, although there was a non-significant trend toward slightly lower SHBG at week 12 [6]. Lower SHBG could theoretically raise free testosterone, which would be a mild benefit for men on TRT, though the effect size was too small to be clinically meaningful.

Practical Implication for AndroGel Users

Men using AndroGel 1.62% (standard daily dose 40.5 mg delivering approximately 2.5 to 5 mg absorbed testosterone) are already receiving exogenous testosterone. Their hypothalamic-pituitary-gonadal axis is suppressed by negative feedback. Melatonin's potential LH-suppressing effect, even if present, would have no meaningful downstream impact on a man whose own testosterone production is already intentionally replaced by the gel.

Glucose Tolerance: The Most Clinically Relevant Overlap

Both testosterone and melatonin affect glucose metabolism, and men on TRT are often already monitoring for metabolic changes. Understanding how these effects interact is the most important part of evaluating this combination.

How Testosterone Therapy Changes Glucose Metabolism

The Endocrine Society's 2018 clinical practice guideline on testosterone therapy states: "Testosterone therapy in men with hypogonadism and type 2 diabetes or metabolic syndrome may improve insulin resistance and glycemic control" [7]. The TIMES2 trial (N=220 hypogonadal men with type 2 diabetes or metabolic syndrome) showed that testosterone undecanoate injections significantly reduced HOMA-IR (a measure of insulin resistance) at 12 months compared to placebo [8]. While AndroGel is a different formulation than injectable testosterone undecanoate, the metabolic direction of effect is the same.

This means that over weeks to months, AndroGel tends to push glucose metabolism in a favorable direction for most hypogonadal men.

How Melatonin Affects Glucose Metabolism

The picture with melatonin is dose-dependent and timing-dependent. Physiologic nighttime melatonin concentrations (roughly 50 to 200 pg/mL) play a normal role in the circadian regulation of glucose metabolism. Supraphysiologic doses from oral supplements, which can push serum melatonin to 1,000 to 10,000 pg/mL depending on dose, are where the glucose signal changes [4].

A meta-analysis in Obesity Reviews (2020, k=16 randomized controlled trials) found that melatonin supplementation at doses between 2 and 10 mg was associated with modestly higher fasting glucose (weighted mean difference +1.7 mg/dL, 95% CI 0.3 to 3.1 mg/dL, P<0.05) in adults with metabolic syndrome, though not in metabolically healthy adults [9].

The table below summarizes how dose relates to glucose risk, to help clinicians and patients calibrate conversations about melatonin use alongside AndroGel.

| Melatonin Dose | Approximate Serum Peak | Glucose Risk Signal | Practical Guidance | |---|---|---|---| | 0.5 mg | ~500 pg/mL | Minimal in most studies | Preferred starting dose | | 1 mg | ~1,000 pg/mL | Low in metabolically healthy men | Acceptable; monitor if diabetic | | 3 mg | ~3,000 pg/mL | Mild signal in metabolic syndrome | Use cautiously; check fasting glucose | | 5 to 10 mg | ~5,000 to 10,000 pg/mL | Consistent signal in at-risk patients | Discuss with prescriber; routine use not recommended |

Melatonin and Sleep Quality in Men on TRT

Sleep problems are common in men with hypogonadism. Low testosterone is independently associated with reduced sleep efficiency and shorter sleep duration. Restoring testosterone with TRT often improves sleep, though not always completely.

Why Men on AndroGel Reach for Melatonin

A cross-sectional analysis published in Sleep Medicine (2021) found that men with hypogonadism reported sleep onset latency averaging 28 minutes, compared to 18 minutes in eugonadal controls matched for age and BMI [10]. Even after six months of TRT, about 30% of participants still reported difficulty initiating sleep. For these men, melatonin is an intuitive, inexpensive choice.

Does Sleep Improvement from Melatonin Benefit TRT Outcomes?

Sleep quality directly affects testosterone secretion in healthy men. A landmark study in JAMA (2011, N=10) showed that restricting sleep to 5 hours per night for one week reduced daytime testosterone levels by 10 to 15% in young healthy men [11]. While this finding was in eugonadal men, and men on AndroGel receive exogenous testosterone regardless of sleep quality, better sleep still matters for treatment satisfaction, mood, and adherence.

A 2022 systematic review in Sleep Medicine Reviews (k=22 trials) confirmed that melatonin 0.5 to 5 mg shortened sleep onset latency by a mean of 7.2 minutes and improved subjective sleep quality scores across diverse adult populations [12]. The lower end of that dose range (0.5 to 1 mg) produced effects comparable to higher doses in most studies, with fewer metabolic signals.

Skin Transfer and Application Site Interactions

AndroGel carries an FDA black box warning about unintended testosterone transfer to women and children through skin contact with the application site. Melatonin has no relevance to this risk. The two substances do not interact at the skin level.

Safe Application Practices Remain the Same

Men using AndroGel should apply the gel to shoulders, upper arms, or abdomen (per the prescribing information for AndroGel 1.62%), allow it to dry for 5 minutes, cover the area with clothing, and wash hands thoroughly after application [13]. None of these steps change based on melatonin use.

Timing of AndroGel Application vs. Melatonin

AndroGel is typically applied in the morning to align with the natural circadian peak of testosterone secretion and to minimize nocturnal skin-contact transfer risk. Melatonin is taken 30 to 60 minutes before bed. The two are therefore separated by 12 to 16 hours in a standard regimen, which means any theoretical pharmacokinetic window for interaction (if one existed) would be clinically irrelevant by bedtime.

Drug Interactions: What Else on Your TRT Regimen Might Interact with Melatonin?

Men on AndroGel are sometimes prescribed additional medications as part of a broader hormone optimization protocol: anastrozole (an aromatase inhibitor), HCG (human chorionic gonadotropin), or clomiphene citrate. Melatonin's interaction profile with these agents deserves brief attention.

Anastrozole and Melatonin

Anastrozole is metabolized by CYP3A4, CYP1A2, and CYP2C8. Because melatonin is a substrate of CYP1A2, there is a theoretical possibility of mild competitive inhibition if both are present simultaneously in high concentrations. However, the clinical significance of this overlap appears negligible. No pharmacokinetic interaction study between anastrozole and melatonin has been published in the peer-reviewed literature as of January 2025, and no interaction warning appears in the FDA prescribing information for anastrozole [14].

Clomiphene and Melatonin

Clomiphene citrate (used off-label in some men to stimulate endogenous testosterone production) is metabolized by CYP2D6 and CYP3A4. No meaningful overlap with melatonin's CYP1A2 pathway has been identified [15].

Fluvoxamine: The Indirect Caution

If a man on AndroGel is also prescribed fluvoxamine (an SSRI and potent CYP1A2 inhibitor), that drug can dramatically raise melatonin serum levels. A pharmacokinetic study showed that fluvoxamine co-administration increased melatonin AUC by approximately 12-fold [2]. Men on fluvoxamine plus AndroGel who want to use melatonin should use 0.5 mg or less, and should discuss the combination with their prescriber.

Who Should Be Most Cautious?

Most men on AndroGel who want to try melatonin for occasional sleep support are not in a high-risk category. However, certain subgroups warrant more careful thought.

Men with Type 2 Diabetes or Prediabetes

The pharmacodynamic glucose concern is most relevant here. A man on AndroGel who also carries a diagnosis of type 2 diabetes or prediabetes should start with 0.5 mg melatonin, check fasting glucose after two to four weeks of regular use, and discuss results with their prescriber. The Endocrine Society notes that "glucose metabolism should be monitored in hypogonadal men starting testosterone therapy," and adding a glucose-affecting supplement compounds the monitoring rationale [7].

Men Taking CYP1A2 Inhibitors

As noted above, drugs that inhibit CYP1A2 (fluvoxamine, ciprofloxacin, enoxacin) will markedly raise melatonin exposure. Men on these agents should use the lowest available melatonin dose.

Men with Sleep Apnea

Obstructive sleep apnea is more common in men with obesity and hypogonadism. Melatonin does not treat sleep apnea and should not replace CPAP therapy. Some clinicians worry that sedating supplements could blunt arousal responses in apneic men, though the evidence for melatonin specifically is limited. Men with untreated sleep apnea should prioritize polysomnography over supplement trials.

Practical Dosing and Monitoring Guidance

The following recommendations reflect the published literature and standard telehealth prescribing practice. They are not a substitute for individualized medical advice.

Starting Dose

Use 0.5 mg melatonin taken 30 to 60 minutes before target sleep time. Most adults do not need more than 1 mg to achieve a meaningful sleep-onset benefit [12]. The widespread consumer habit of taking 5 to 10 mg is not supported by dose-response data and increases both glucose and next-morning sedation risk.

Timing with AndroGel

Apply AndroGel in the morning as directed. Take melatonin at night. No dose-separation window beyond standard daily timing is necessary.

Monitoring Schedule

• At baseline: fasting glucose and HbA1c (standard TRT monitoring per Endocrine Society guidelines)
• At 3 months after adding regular melatonin: repeat fasting glucose if using doses above 1 mg or if diabetic
• Annually: routine metabolic panel as part of ongoing TRT monitoring

When to Stop or Reduce Melatonin

Discontinue melatonin and contact your prescriber if fasting glucose rises more than 15 mg/dL above baseline without dietary explanation, or if you experience significant next-morning drowsiness that affects safety-sensitive activities (driving, operating machinery).